Phathom Pharmaceuticals Inc Phase 3 PHALCON-HP Results Corporate Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Phathom Pharmaceuticals Phase III PHALCON-HP Top Line Trial Results Conference Call. (Operator Instructions)
I would now like to hand the conference over to Todd Branning, Phathom's Chief Financial Officer. Thank you. Please go ahead, sir.
Good afternoon, and thank you for joining us. My name is Todd Branning, and I am Phathom's Chief Financial Officer. Today is a very important day for Phathom, and we're excited to discuss the results from our PHALCON-HP Phase III trial that we shared earlier and to answer questions you have regarding the data.
As a housekeeping item, before we begin the meeting, I want to make you aware that at the end of today's presentations, we will hold a Q&A session with our presenters, Terrie Curran, our President and Chief Executive Officer; and Azmi Nabulsi, our Chief Operating Officer; as well as other members of our leadership team; Martin Gilligan, our Chief Commercial Officer; Tom Harris, Senior Vice President, Regulatory Affairs; and me.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
